26.2 C
New York
Tuesday, June 9, 2026

Tag: CCA FVT

newssourceFORcompanyinformationcontent1marketreleases

Prologis to Announce Second Quarter 2026 Results July 16, 2026

SAN FRANCISCO, June 4, 2026 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD) will host a webcast and conference call with senior management to discuss its...

Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026

NEWTON, Mass., June 3, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it...

Everest Medicines to Announce 2025 Interim Results on August 29, 2025

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and...

VNET to Announce Unaudited Second Quarter 2025 Financial Results on August 21, 2025

BEIJING, Aug. 7, 2025 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services...

Nektar to Announce Financial Results for the Second Quarter on Thursday, August 7, 2025, After Close of U.S.-Based Financial Markets

SAN FRANCISCO, July 31, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter on Thursday, August 7, 2025, after the...

Dana Incorporated to Announce 2025 Second-quarter Financial Results, Host Conference Call and Webcast on August 5

MAUMEE, Ohio, July 31, 2025 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) will release its 2025 second-quarter financial results on Tuesday, August 5, 2025. A...

Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025

MADISON, Wis., July 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2025, ended...

Pixelworks to Announce Second Quarter 2025 Financial Results on August 12

PORTLAND, Ore., July 29, 2025 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, will release its second...

NACCO INDUSTRIES ANNOUNCES DATES OF 2025 SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL

CLEVELAND, July 29, 2025 /PRNewswire/ -- NACCO Industries® (NYSE: NC) will release its 2025 Second Quarter financial results after the close of the market...

Reminder: Stepan to Announce Second Quarter 2025 Results on July 30, 2025

NORTHBROOK, Ill., July 23, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its second quarter 2025 earnings results on Wednesday, July 30, 2025 at...

QuidelOrtho to Report Second Quarter 2025 Financial Results

SAN DIEGO, July 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed...

Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 5, 2025

DUBLIN, July 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 second quarter financial results on...

Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference Call

ALHAMBRA, Calif., July 22, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a...

Media Advisory – Neo Performance Materials Inc. Second Quarter 2025 Earnings Release & Webcast

TORONTO, July 22, 2025 /CNW/ - Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF) will report its second-quarter results for the period ended...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCCA FVT

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers